BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chavda VP, Ertas YN, Walhekar V, Modh D, Doshi A, Shah N, Anand K, Chhabria M. Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds. Front Pharmacol 2021;12:702611. [PMID: 34483905 DOI: 10.3389/fphar.2021.702611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Almajidi YQ, M Kadhim M, Alsaikhan F, Turki Jalil A, Hassan Sayyid N, Alexis Ramírez-Coronel A, Hassan Jawhar Z, Gupta J, Nabavi N, Yu W, Ertas YN. Doxorubicin-loaded micelles in tumor cell specific chemotherapy. Environ Res 2023;:115722. [PMID: 36948284 DOI: 10.1016/j.envres.2023.115722] [Reference Citation Analysis]
2 Zhu J, Wang L, Yang Y, Han M, Yang Y, Feng R, Hu Y. Bruceine D and afatinib combination inhibits ovarian cancer cells proliferation and migration through DNA damage repair and EGFR pathway. J Investig Med 2023;:10815589231158043. [PMID: 36859802 DOI: 10.1177/10815589231158043] [Reference Citation Analysis]
3 Miroshnichenko II, Valdman EA, Kuz'min II. Old Drugs, New Indications (Review). Razrabotka i registraciâ lekarstvennyh sredstv 2023;12:182-190. [DOI: 10.33380/2305-2066-2023-12-1-182-190] [Reference Citation Analysis]
4 Bezbaruah R, Ghosh M, Kumari S, Nongrang L, Ali SR, Lahiri M, Waris H, Kakoti BB. Role of AI and ML in Epidemics and Pandemics. Bioinformatics Tools for Pharmaceutical Drug Product Development 2023. [DOI: 10.1002/9781119865728.ch15] [Reference Citation Analysis]
5 Parikh S, Patel R, Khunt D, Chavda VP, Vora L. Data Analytics and Data Visualization for the Pharmaceutical Industry. Bioinformatics Tools for Pharmaceutical Drug Product Development 2023. [DOI: 10.1002/9781119865728.ch4] [Reference Citation Analysis]
6 Khadela A, Popat S, Ajabiya J, Valu D, Savale S, Chavda VP. AI, ML and Other Bioinformatics Tools for Preclinical and Clinical Development of Drug Products. Bioinformatics Tools for Pharmaceutical Drug Product Development 2023. [DOI: 10.1002/9781119865728.ch12] [Reference Citation Analysis]
7 Kumela AG, Gemta AB, Hordofa AK, Desta TA, Dangish M, Mekonnen HD. Optoplasmonic biosensor for lung cancer telediagnosis: Design and simulation analysis. Sensors International 2023. [DOI: 10.1016/j.sintl.2023.100232] [Reference Citation Analysis]
8 Bogari HA, Elhady SS, Darwish KM, Refaey MS, Mohamed RA, Abdelhameed RFA, Almalki AJ, Aldurdunji MM, Lashkar MO, Alshehri SO, Malatani RT, Yamada K, Khedr AIM. Molecular and Biological Investigation of Isolated Marine Fungal Metabolites as Anticancer Agents: A Multi-Target Approach. Metabolites 2023;13. [PMID: 36837781 DOI: 10.3390/metabo13020162] [Reference Citation Analysis]
9 Chavda VP, Balar PC, Patel SB. Interventional nanotheranostics in hepatocellular carcinoma. Nanotheranostics 2023;7:128-41. [PMID: 36793354 DOI: 10.7150/ntno.80120] [Reference Citation Analysis]
10 Chavda VP, Soni S, Vora LK, Soni S, Khadela A, Ajabiya J. mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines (Basel) 2022;10. [PMID: 36560560 DOI: 10.3390/vaccines10122150] [Reference Citation Analysis]
11 Chavda VP, Ping FF, Chen ZS. An Impact of COVID-19 on Cancer Care: An Update. Vaccines (Basel) 2022;10. [PMID: 36560482 DOI: 10.3390/vaccines10122072] [Reference Citation Analysis]
12 Hashemi M, Ghadyani F, Hasani S, Olyaee Y, Raei B, Khodadadi M, Ziyarani MF, Basti FA, Tavakolpournegari A, Matinahmadi A, Salimimoghadam S, Aref AR, Taheriazam A, Entezari M, Ertas YN. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104112] [Reference Citation Analysis]
13 Chavda VP, Redwan EM. SARS-CoV-2: Immunopeptidomics and Other Immunological Studies. Vaccines 2022;10:1975. [DOI: 10.3390/vaccines10111975] [Reference Citation Analysis]
14 Chavda VP, Kumar A, Banerjee R, Das N. Ayurvedic and Other Herbal Remedies for Dengue: An Update. Clinical Complementary Medicine and Pharmacology 2022;2:100024. [DOI: 10.1016/j.ccmp.2022.100024] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Chavda VP, Chen Y, Dave J, Chen ZS, Chauhan SC, Yallapu MM, Uversky VN, Bezbaruah R, Patel S, Apostolopoulos V. COVID-19 and vaccination: myths vs science. Expert Rev Vaccines 2022. [PMID: 35980281 DOI: 10.1080/14760584.2022.2114900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Chavda VP, Chhabria MT, Apostolopoulos V. Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes. Biologics 2022;2:165-70. [DOI: 10.3390/biologics2030013] [Reference Citation Analysis]
17 Chavda VP, Patel AB, Mistry KJ, Suthar SF, Wu ZX, Chen ZS, Hou K. Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges. Front Oncol 2022;12:867655. [PMID: 35425710 DOI: 10.3389/fonc.2022.867655] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
18 Huang Z, Chavda VP, Vora LK, Gajjar N, Apostolopoulos V, Shah N, Chen Z. 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update. Front Pharmacol 2022;13:899633. [DOI: 10.3389/fphar.2022.899633] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
19 Chen RP, Chavda VP, Patel AB, Chen ZS. Phytochemical Delivery Through Transferosome (Phytosome): An Advanced Transdermal Drug Delivery for Complementary Medicines. Front Pharmacol 2022;13:850862. [PMID: 35281927 DOI: 10.3389/fphar.2022.850862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
20 Chavda VP, Vihol D, Mehta B, Shah D, Patel M, Vora LK, Pereira-Silva M, Paiva-Santos AC. Phytochemical-loaded liposomes for anticancer therapy: an updated review. Nanomedicine (Lond) 2022. [PMID: 35259920 DOI: 10.2217/nnm-2021-0463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
21 He L, Liang P, Zeng H, Huang G, Wu J, Zhang Y, Cui Y, Huang W, Yang D. A Predictive Model for Nonsentinel Node Status after Sentinel Lymph Node Biopsy in Sentinel Lymph Node-Positive Chinese Women with Early Breast Cancer. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/7704686] [Reference Citation Analysis]